Adaptimmune
Adaptimmune is an England-based biopharmaceutical company that researches and develops novel cell therapeutics for the treatment of cancer and infectious diseases.
Work at Adaptimmune in HR or recruiting? Claim this page
Headcount trend
Adaptimmune went from 263 employees in Oct 2024 to 86 in Sep 2026. Apr to Sep 2026: 0 people joined, 5 left.
Org structure
Headcount by department
H-1B sponsorship
Peer reviews
Worked with someone at Adaptimmune?
Anonymous peer reviews on OffTheRecord
Similar companies
Adaptimmune FAQ
How many employees does Adaptimmune have?
Adaptimmune has about 86 employees, unchanged over the 3 months to Sep 2026.
Does Adaptimmune sponsor H1B visas?
Yes. Adaptimmune filed 1 H1B (LCA) application in FY2024, according to the latest U.S. Department of Labor disclosures. It was for a Engineering role.
What is Adaptimmune's revenue per employee?
Adaptimmune makes about $698K in revenue per employee, based on $60M annual revenue and 86 employees.
Is Adaptimmune a public company?
Yes. Adaptimmune is publicly traded under the ticker ADAP on NASDAQ.
Data from Company Prospectus, DOL LCA disclosures, WARN notices and 6figr salary profiles.